Is ultrasound valuable in breast cancer screening

Slides:



Advertisements
Similar presentations
Adrenal Incidentaloma: Evidence Based Approach
Advertisements

Breast Imaging Olga Hatsiopoulou Consultant Radiologist
†Source: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department.
BREAST CANCER SCREENING Anoop Agrawal, M.D.. NEW USPSTF BREAST SCREENING GUIDELINES Published by US Preventative Screening Task Force in November 2009.
Breast Cancer Screening What’s New to Know? The Issue of Breast Density Catherine Babcook MD Partner, Mountain Medical Physician Specialists Medical Director.
Breast MR Imaging Workshop th September 2014 High-Risk Screening Evidence-based Clinical Indications for Breast MRI Dr. Muhamad Zabidi Ahmad, AMDI.
Breast Density A patient guide.
Computer Aided Diagnosis: CAD overview
Breast Histopathology : Mammography
In The Nam of God.
Breast Cancer By: Will Wellman. About Breast Cancer  Breast cancer is a form of cancer that happens in the cells of the breast.  Breast cancer is most.
Breast Neoplasm In this section we will be discussing breast neoplasm.
Breast Imaging Made Brief and Simple
Breast Cancer screening in the NHS Dr D J Rohan Subasinghe.
In The Nam of God.
Background on: Breast Cancer, X-Ray and MRI Mammography
The Cancer Pedigree BRCA What?. Outline Introduction: Understanding the weight of genetics in Ovarian Breast Cancer BRCA 1 and BRCA 2 Genes – Function.
MAMOGRAPHY. Mammography is the process of using low- energy X-rays (usually around 30 kVp) to examine the human breast, which is used as a diagnostic.
SYB 1 Erin Gundersen MS IV. Breast Cancer Breast Cancer.
ACRIN Protocol 6666 ACRIN Protocol 6666 Screening Breast Ultrasound in High-Risk Women Made possible by grants from the Avon Foundation and National Cancer.
MedPix Medical Image Database COW - Case of the Week Case Contributor: Russell A. Patterson Affiliation: Uniformed Services University.
Diagnostic Cases. Goals & Objectives Highlight Bayesian and Boolean processes used in classic diagnosis Demonstrate use/misuse of tests for screening.
Early Detection Of Breast Cancer A Formidable Challenge.
DUAL ENERGY CONTRAST ENHANCED SPECTRAL MAMMOGRAM : AS A PROBLEM SOLVING TOOL IN EQUIVOCAL CASES Abstract ID IRIA-1121.
DR (MRS) AUGUSTINA BADU-PEPRAH MB Ch B, FWACS RADIOLOGIST KATH.
Imaging examinations of breasts
WORK UP & MANAGEMENT OF SOLITARY PULMONARY NODULE Seifu B Oct-04, 2007.
Improvement in Screening Radiologists’ Performance in an Organized Screening Program Nancy A. T. Wadden, MD, FRCPC Gregory Doyle, BSc, MBA Breast Screening.
Introduction to Clinical Radiology: The Breast
How will you approach the 35-year old, with a 2x2x2cm, firm, mobile, well-circumscribed non-tender mass on her R breast?
Breast Cancer. Introduction  As old as 1600 BC  Emerges from inner lining of milk ducts  Or the lobules that supply milk  Types:  DCIS  LCIS.
Understanding Factors That Affect Mammography Performance: Contribution of the BCSC Bonnie C. Yankaskas, PhD Professor of Radiology University of North.
In The Name of God BREAST IMAGING N. Ahmadinejad Medical Imaging Center TUMS.
Tolerability of Breast Cancer Screening, Diagnostic and Biopsy Procedures: An ACRIN 6666 Substudy Mark D. Schleinitz, MD, MS Dina DePalo Jeffrey Blume,
IN THE NAME OF GOD.
THIRD CLASSIFICATION OF MICROCALCIFICATION STAGES IN MAMMOGRAPHIC IMAGES THIRD REVIEW Supervisor: Mrs.P.Valarmathi HOD/CSE Project Members: M.HamsaPriya( )
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
MAMMOGRAM COLLAGE OF MEDICINE /RADIOLOGY DEPARTMENT.
Breast Thermography Len Saputo, MD Maurice Bales Merritt Hospital Tumor Board Presentation August 27, 2014.
Iraj Khalkhali M.D., F.A.C.R., F.A.C.N.M.
Dr. Julia Flukinger Breast Radiologist, Director Breast MRI, Advanced Radiology May 21, 2106.
Thursday Case of the Day History: The hypothetical results from a clinical trial of computer-aided detection (CADe) used in mammographic screening of 5,000,000.
The Natural History of Benign Thyroid Nodules JAMA. 2015;313(9): doi: /jama Modulator Prof. 전숙 / R1 윤수진.
Case D Karmi Margaret G. Marcial. How will you approach the 35-year old, with a 2 x 2 x 2cm, firm, mobile, well-circumscribed non-tender mass on her R.
Med Info 402 – Spring  Introduction of team  Introduction of case  Presentation of case  Conclusion  Questions.
Moving from observation to intervention Developing Interventions to Improve Mammography Interpretation: AIM Study Design sponsored by: American Cancer.
J Clin Endocrinol Metab, Sep 2006, 91(9):
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins CHAPTER 22 Breast Cancer Diagnostic Technologies: Today and Tomorrow.
Application of the breast imaging reporting and data system final assessment system in sonography of palpable breast lesions and reconsideration of the.
Cancer prevention and early detection
Breast Screening and Assessment
Number of women referred for further investigation in relation to all imaged women – recall rate
Cancer prevention and early detection
Cancer prevention and early detection
Indications for Breast MR Imaging
Mammograms and Breast Exams: When to start /stop mammograms
SON 2147 Sonography of the Breast
Dr. Tauseef Ismail Assistant Professor Dept of C Med. KGMC
The impact of simulated motion blur on lesion detection performance in Full Field Digital Mammography Ahmed K. Abdullah1,2, John Thompson2, Claire Mercer2,
Breast Imaging Ravi Adhikary, MD.
BCSC as a Platform for Comparative Effectiveness Research
Abbreviated Protocols for Breast Cancer Screening
The Research Question What is the evidence on diagnostic test performance and clinical outcomes of supplemental screening of women with dense breasts with.
Stamatia Destounis, MD, FACR, FSBI, FAIUM
Breast Cancer Guideline Update – Sharp Focus on Who is at Risk
Marion C.W. Henry, MD Yale University
Diagnosis of breast cancer in women age 40 and younger: Delays in diagnosis result from underuse of genetic testing and breast imaging 95% of patients.
imaging modalities for Breast screening
Evidence Based Diagnosis
Breast Cancer Screening in High-Risk Men: A 12-Year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes Mammography screening.
Presentation transcript:

Is ultrasound valuable in breast cancer screening G. Villeirs Genitourinary Radiology Ghent University Hospital

Introduction Screening = the evaluation of a population of asymptomatic women in an effort to detect unsuspected disease at a time when cure is still possible

Introduction Screening = the evaluation of a population of asymptomatic women in an effort to detect unsuspected disease at a time when cure is still possible

Introduction high specificity high sensitivity avoid false positives! high sensitivity find as many subclinical cancers as possible! feasible and reproducible low cost

Introduction Screening = the evaluation of a population of asymptomatic women in an effort to detect unsuspected disease at a time when cure is still possible

Introduction Screening = the evaluation of a population of asymptomatic women in an effort to detect unsuspected disease at a time when cure is still possible

Introduction high specificity high sensitivity avoid false positives! high sensitivity find as many subclinical cancers as possible! feasible and reproducible low cost

Introduction high specificity high sensitivity avoid false positives! high sensitivity find as many subclinical cancers as possible! feasible and reproducible low cost

Introduction Screening = the evaluation of a population of asymptomatic women in an effort to detect unsuspected disease at a time when cure is still possible

Introduction Screening = the evaluation of a population of asymptomatic women in an effort to detect unsuspected disease at a time when cure is still possible

Introduction

Introduction

Introduction

Introduction

Introduction

Introduction

Introduction

Introduction

Introduction

Introduction high specificity high sensitivity avoid false positives! high sensitivity find as many subclinical cancers as possible! feasible and reproducible low cost

Introduction high specificity high sensitivity avoid false positives! high sensitivity find as many subclinical cancers as possible! feasible and reproducible low cost

Introduction high specificity high sensitivity avoid false positives! high sensitivity find as many subclinical cancers as possible! feasible and reproducible low cost

MAMMOGRAPHIC SCREENING

Mammographic Screening

Mammographic Screening Sensitivity 88% 83% 69% 62% 8,4% 48,1% 36,2% 7,3% 77% *Rosenberg RD. Radiology 1998;209:511-518 Yankaskas. Am J Roentgenol 2001;177:543 Carney. Ann Intern Med 2003;138:168

Mammographic Screening Specificity 97% 93% 91% 90% 8,4% 48,1% 36,2% 7,3% 93% *Carney, Ann Intern Med 2003;138:168

Mammographic Screening Sensitivity of 77% 4 out of 5 asymptomatic lesions are detected! Specificity of 93% acceptable number of false positives!

Mammographic Screening Sensitivity of 77% 4 out of 5 asymptomatic lesions are detected! Specificity of 93% acceptable number of false positives!

Mammographic Screening Sensitivity of 77% 1 out of 5 asymptomatic lesions are missed! Specificity of 93% acceptable number of false positives!

MAMMOGRAPHICALLY OCCULT ?

Mammographically Occult ? Was the mammogram of high enough quality? good positioning? technically good? Were previous mammograms available for comparison?

Mammographically Occult ? Was the mammogram of high enough quality? good positioning? technically good? Were previous mammograms available for comparison?

Mammographically Occult ? Was the mammogram of high enough quality? good positioning? technically good? Were previous mammograms available for comparison?

Mammographically Occult ? Was the mammogram of high enough quality? good positioning? technically good? Were previous mammograms available for comparison?

IMPORTANCE OF TRUE SONOGRAPHYCALLY DETECTED LESIONS

3.2 cm

Importance of true sonographycally detected lesions

Importance of true sonographycally detected lesions Small lesions are difficult to detect on US subtle signs small spiculations, lobulations, microcalcifications… lower resolution of sonography observer bias who has a lesion? where is the lesion?

Importance of true sonographycally detected lesions Small lesions are difficult to detect on US subtle signs small spiculations, lobulations, microcalcifications… lower resolution of sonography observer bias who has a lesion? where is the lesion?

Mammography Sonography

Importance of true sonographycally detected lesions Prevalence of (small) malignant lesions is much lower than prevalence of (small) benign lesions Excess of false positive findings!!

Importance of true sonographycally detected lesions Small lesions are difficult to detect on US subtle signs small spiculations, lobulations, microcalcifications… lower resolution of sonography observer bias who has a lesion? where is the lesion?

Importance of true sonographycally detected lesions Small lesions are difficult to detect on US subtle signs small spiculations, lobulations, microcalcifications… lower resolution of sonography observer bias who has a lesion? where is the lesion?

FEASIBILITY AND REPRODUCIBILITY

Feasibility and Reproducibility A screening examination should be easy to perform and reproducible extra 1.5 – 2 hours per mammographic unit per day (10 minutes per examination) quality assurance??? ultrasound equipment radiologist double reading

COST OF SCREENING

Cost of Screening Addition of sonography increases overall screening cost (if funded separately) due to: sonography reimbursement extra interventions (false positives)

Cost of Screening Other prevention strategies anti-tobacco campaigns investments in safer traffic prevention of infectious diseases suicide prevention …

SCIENTIFIC PROOF

Scientific Proof Ultrasound Screening Studies Buchberger, AJR 1999;173:921-927 Kaplan, Radiology 2001;221:641-649 Kolb, Radiology 2002;225:165-175 Crystal, AJR 2003;181:177-182 Corsetti, Radiol Med 2006;111:480-488

Scientific Proof Results 29857 women mammo + US screening 1327 (4,6%) referred for intervention (90% cytology or core-biopsy, 10% open biopsy) 103 mammographically occult tumors detected (µ = 1 cm) = 3,4/1000 women 1224 false positive!!! = B/M 12/1 Buchberger, AJR 1999;173:921-927 Kaplan, Radiology 2001;221:641-649 Kolb, Radiology 2002; 2002;225:165-175 Crystal, AJR 2003;181:177-182 Corsetti, Radiol Med (Torino) 2006;111:480-488

Scientific Proof Discussion Statistical law ↑ sensitivity = ↓ specificity ↓ sensitivity = ↑ specificity

Scientific Proof Discussion Increase of sensitivity by Biopsy of all microcalcifications Biopsy of all mammographic nodules Addition of sonography Screening with MRI!

Scientific Proof Discussion Seek for the highest sensitivity between the limits of an acceptable false positive rate EUROPEAN GUIDELINES

Screening No Screening Total Participation 35% 35.000 65.000 100.000 3/1000/year 105 195 300 Mammography : 77% 81 81 Mammo + US : 85% 89 89 +8 (+10%) Participation 45% 45.000 55.000 100.000 3/1000/year 135 165 300 Mammography : 77% 104 104 +23 (+28%)

Screening No Screening Total Participation 35% 35.000 65.000 100.000 3/1000/year 105 195 300 Mammography : 77% 81 81 Mammo + US : 85% 89 89 +8 (+10%) Participation 75% 75.000 25.000 100.000 3/1000/year 225 75 300 Mammography : 77% 173 173 +92 (+113%)

Participation versus US FIRST let’s increase the participation rate THEN let’s discuss the additional value of US

HIGH RISK POPULATION

High Risk Population High risk Higher cancer prevalence Familial breast cancer or genetic predisposition Mammographically dense breasts Higher cancer prevalence High sensitivity needed Specificity less critical

High Risk Population 1517 women mammo + echo (2/3/4) 1199 “normal risk” 28 (2,34%) referred for intervention 3 tumors detected (detection rate 0,25%) B/M-ratio 8,33/1 318 “high risk” 10 (3,14%) referred for intervention 4 tumors detected (detection rate 1,27%!!) B/M-ratio 1,50/1!! Crystal, AJR 2003;181:177-182

CONCLUSIONS

Conclusions Mammography is the best screening tool Sonography is an optimal diagnostic tool Use of sonography as an adjunct to mammographic screening is problematic and should currently not be adopted Probably useful in screening of high risk women with dense breasts